Form 8-K - Current report:
SEC Accession No. 0001193125-24-252054
Filing Date
2024-11-06
Accepted
2024-11-06 16:17:01
Documents
16
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d889134d8k.htm   iXBRL 8-K 23450
2 EX-99.1 d889134dex991.htm EX-99.1 84810
6 GRAPHIC g889134g1106235601226.jpg GRAPHIC 2696
7 GRAPHIC g889134g1106235644255.jpg GRAPHIC 2696
  Complete submission text file 0001193125-24-252054.txt   248389

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA slno-20241106.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE slno-20241106_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slno-20241106_pre.xml EX-101.PRE 11261
19 EXTRACTED XBRL INSTANCE DOCUMENT d889134d8k_htm.xml XML 3667
Mailing Address 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065
Business Address 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065 650-213-8444
SOLENO THERAPEUTICS INC (Filer) CIK: 0001484565 (see all company filings)

EIN.: 770523891 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36593 | Film No.: 241431227
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)